We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$1.12B
AUM Growth
-$17.8M
Cap. Flow
-$25.9M
Cap. Flow %
-2.31%
Top 10 Hldgs %
26.94%
Holding
385
New
24
Increased
97
Reduced
207
Closed
14

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.99M
2
JNJ icon
Johnson & Johnson
JNJ
+$2.64M
3
AIG icon
American International
AIG
+$2.37M
4
MRK icon
Merck
MRK
+$1.88M
5
WEC icon
WEC Energy
WEC
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 14.41%
2 Financials 13.91%
3 Technology 11.52%
4 Industrials 7.8%
5 Consumer Discretionary 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EZU icon
1
iShare MSCI Eurozone ETF
EZU
$9.54B
$99.1M 8.83%
2,640,940
+8,260
+0.3% +$326K
VWO icon
2
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$38.5M 3.43%
940,800
-14,510
-2% -$623K
AMJ
3
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$38M 3.38%
958,960
-271,241
-22% -$11.8M
AAPL icon
4
Apple
AAPL
$4.76T
$22.8M 2.03%
727,456
-11,944
-2% -$382K
CVS icon
5
CVS Health
CVS
$140B
$20.1M 1.79%
191,403
-5,809
-3% -$594K
PFE icon
6
Pfizer
PFE
$142B
$18M 1.6%
565,692
-3,910
-0.7% -$127K
AET
7
DELISTED
Aetna Inc
AET
$18M 1.6%
141,066
-8,869
-6% -$1.01M
JNJ icon
8
Johnson & Johnson
JNJ
$612B
$17.5M 1.56%
179,242
+26,407
+17% +$2.64M
CMCSA icon
9
Comcast
CMCSA
$84.7B
$15.7M 1.4%
523,594
-11,290
-2% -$331K
XOM icon
10
ExxonMobil
XOM
$640B
$14.7M 1.31%
181,251
-10,648
-6% -$915K
NOC icon
11
Northrop Grumman
NOC
$75.1B
$14.6M 1.3%
92,279
-3,219
-3% -$515K
DIS icon
12
Walt Disney
DIS
$168B
-132,390
Closed -$14.5M
UNH icon
13
UnitedHealth
UNH
$395B
$13.9M 1.24%
114,266
-5,669
-5% -$671K
MSFT icon
14
Microsoft
MSFT
$2.88T
$13.6M 1.21%
308,237
+18,741
+6% +$855K
IWC icon
15
iShares Micro-Cap ETF
IWC
$1.46B
$13.5M 1.21%
166,119
-1,002
-0.6% -$80.5K
ELV icon
16
Elevance Health
ELV
$84.6B
$13.5M 1.21%
82,457
+183
+0.2% +$29.2K
CVX icon
17
Chevron
CVX
$384B
$13.1M 1.17%
135,896
+7,441
+6% +$781K
TWX
18
DELISTED
Time Warner Inc
TWX
$13.1M 1.17%
149,883
-4,864
-3% -$415K
BRK.B icon
19
Berkshire Hathaway Class B
BRK.B
$1.05T
$13.1M 1.17%
96,190
-3,106
-3% -$443K
KYTH
20
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$12.8M 1.14%
170,454
-4,000
-2% -$214K
MET icon
21
MetLife
MET
$60.1B
$12.8M 1.14%
256,341
+12,747
+5% +$604K
FEZ icon
22
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.34B
$12.3M 1.1%
329,229
-3,145
-0.9% -$124K
INTC icon
23
Intel
INTC
$524B
$12.3M 1.09%
403,586
+18,970
+5% +$613K
AIG icon
24
American International
AIG
$41.4B
$12.1M 1.08%
195,776
+40,159
+26% +$2.37M
TMO icon
25
Thermo Fisher Scientific
TMO
$195B
$10.7M 0.95%
82,376
-2,750
-3% -$359K

Similar funds

RegentAtlantic Capital's Q2 2015 Portfolio in Review

As of Q2 2015, RegentAtlantic Capital held 385 positions worth $1.12B, down 1.6% from $1.14B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

RegentAtlantic Capital's Q2 2015 filing shows 24 new, 97 increased, 207 reduced and 14 closed positions. Its largest new stake was Allergan plc: 10,025 shares worth $3.04M. The largest sale was Walt Disney, an estimated $14.5M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • RegentAtlantic Capital's largest Q2 2015 buy was Allergan plc: 10,025 shares worth $3.04M.
  • RegentAtlantic Capital added most to Johnson & Johnson in Q2 2015, an estimated $2.64M increase.
  • RegentAtlantic Capital's biggest Q2 2015 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $11.8M.
  • RegentAtlantic Capital fully exited Walt Disney in Q2 2015, selling an estimated $14.5M.
  • RegentAtlantic Capital's ten largest holdings make up 27% of its $1.12B portfolio in Q2 2015.
  • RegentAtlantic Capital opened 24 new positions and closed 14 in Q2 2015.
  • RegentAtlantic Capital's portfolio value fell 1.6% quarter-over-quarter to $1.12B.

Based on RegentAtlantic Capital's 13F filing for Q2 2015, filed 31 Jul 2015.